TY  - JOUR
AU  - Feldman, Gregory J.
AU  - Sousa, Ana R.
AU  - Lipson, David A.
AU  - Tombs, Lee
AU  - Barnes, Neil
AU  - Riley, John H.
AU  - Patel, Sadhana
AU  - Naya, Ian
AU  - Compton, Chris
AU  - Alcazar Navarrete, Bernardino
PY  - 2017
DO  - 10.1007/s12325-017-0626-4
SN  - 0741-238X
UR  - http://hdl.handle.net/10668/18661
T2  - Advances in therapy
AB  - We report the results of the first direct comparison of the once-daily fixed-dose long-acting muscarinic antagonist/long-acting beta(2)-agonist (LAMA/LABA) combinations umeclidinium/vilanterol (UMEC/VI) and tiotropium/olodaterol (TIO/OLO) in patients...
LA  - en
PB  - Springer
KW  - Bronchodilation
KW  - COPD
KW  - LAMA
KW  - LABA
KW  - Long-acting muscarinic antagonist
KW  - Long-acting beta 2-agonist
KW  - Olodaterol
KW  - Tiotropium
KW  - Umeclidinium
KW  - Vilanterol
KW  - Dynamic hyperinflation
KW  - Double-blind
KW  - Copd
KW  - Tiotropium
KW  - Safety
KW  - Bronchodilators
KW  - Combination
KW  - Moderate
TI  - Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study
TY  - research article
VL  - 34
ER  -